s6y

MANGOCEUTICALS, INC.

Ticker
MGRX
CIK
1938046
Industry
Services-Misc Health & Allied Services, NEC
Formerly
MANGOCEUTICALS, INC.

Financials 18

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  7. 10-Q Quarterly Report for period ending Sep 30, 2025
  8. 10-Q/A Quarterly Report for period ending Jun 30, 2025
  9. 10-Q Quarterly Report for period ending Jun 30, 2025
  10. 10-Q Quarterly Report for period ending Mar 31, 2025

All 18 financials filings

News 80

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 80 news filings

Ownership 43

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 43 ownership filings

Prospectus 37

  1. 1-A Offering statement under Regulation A
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  4. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  5. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  6. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  7. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. S-1/A General form of registration statement for all companies including face-amount certificate companies
  10. S-1 General form of registration statement for all companies including face-amount certificate companies

All 37 prospectus filings

Proxies 8

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

Other 61

  1. ARS Annual report to security holders
  2. SCHEDULE 13D/A
  3. EFFECT Notice of Effectiveness
  4. UPLOAD Letter (PDF)
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. 144 Filing for proposed sale of securities under Rule 144
  7. 144 Filing for proposed sale of securities under Rule 144
  8. SCHEDULE 13D/A
  9. EFFECT Notice of Effectiveness
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 61 other filings